Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

1ST-TRIMESTER PRENATAL-DIAGNOSIS OF OSTEOGENESIS IMPERFECTA TYPE-II BY DNA ANALYSIS AND SONOGRAPHY PRENATAL DIAGNOSIS DiMaio, M. S., Barth, R., Koprivnikar, K. E., SUSSMAN, B. L., Copel, J. A., Mahoney, M. J., Byers, P. H., Cohn, D. H. 1993; 13 (7): 589-596

Abstract

Osteogenesis imperfecta type II was diagnosed prenatally by analysis of DNA obtained from chorionic villus sampling (CVS) performed at 12 weeks of gestation in a woman who previously had had an affected child. The father had been shown to be mosaic for a mutation in the gene (COL1A2) which encodes the alpha 2(I) chain of type I collagen. An affected fetus was predicted by detection of the mutation in amplified chorionic villus genomic DNA. Ultrasound examination at 13 weeks 4 days demonstrated femoral deformity and virtual absence of calvarial mineralization. In pregnancies at risk for osteogenesis imperfecta type II, sonographic evidence of skeletal abnormalities may be evident by 13 weeks' gestation.

View details for Web of Science ID A1993LN89500008

View details for PubMedID 8415424